Cargando…
UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb
PURPOSE: Ubiquitin-conjugating enzymes E2S (UBE2S) and E2C (UBE2C), which mediate the biological process of ubiquitination, have been widely reported in various cancers. Numb, the cell fate determinant and tumor suppressor, was also involved in ubiquitination and proteasomal degradation. However, th...
Autores principales: | Guo, Yanjing, Chen, Xinyu, Zhang, Xiaowei, Hu, Xichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969189/ https://www.ncbi.nlm.nih.gov/pubmed/36860312 http://dx.doi.org/10.3389/fonc.2023.992233 |
Ejemplares similares
-
Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
por: Hu, Li, et al.
Publicado: (2021) -
Contributions of UBE2C and UBE2S to meiotic progression of porcine oocytes
por: FUJIOKA, Yoshie A., et al.
Publicado: (2018) -
UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2020) -
High expression of UBE2T predicts poor prognosis and survival in multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2019) -
UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Xiaoyuan, et al.
Publicado: (2021)